{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:23:38Z","timestamp":1783329818039,"version":"3.54.6"},"reference-count":45,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["Unrestricted grand to the Hellenic Thoracic Societ"],"award-info":[{"award-number":["Unrestricted grand to the Hellenic Thoracic Societ"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2026,1,9]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe asthma (SA) imposes a disproportionate burden on patients and healthcare systems worldwide, yet region-specific data from Southern Europe remain scarce. The Greek Severe Asthma Registry (GSAR), an initiative of the Hellenic Thoracic Society, provides the first nationwide characterisation of severe asthma in Greece.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analysed data cross-sectionally from 619 adult patients (median age: 56\u2005years; 61.1% female) with severe asthma, recruited across 13 specialised hospital centres and 11 private respiratory practices between March 2018 and November 2021. Patients were stratified by age of asthma onset, biologic therapy use and maintenance oral corticosteroid (mOCS) dependence. Clinical, inflammatory and treatment characteristics were assessed, alongside exacerbation predictors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study population exhibited substantial disease burden, with 434 patients (70.1%) experiencing \u22651 exacerbation and 149 (24.1%) requiring hospitalisation in the prior year. Late-onset asthma (60.7%) was associated with a faster progression to severe disease, higher exacerbation risk (79.8%\n                      <jats:italic>versus<\/jats:italic>\n                      69.5%, p=0.004), and more frequent cardiometabolic comorbidities\n                      <jats:italic>versus<\/jats:italic>\n                      early-onset asthma. Despite better asthma control (Asthma Control Test \u226520: 61.8%\n                      <jats:italic>versus<\/jats:italic>\n                      50.5%, p=0.012), biologically treated patients (57%) had more severe disease, including lower forced expiratory volume in 1\u2005s (FEV\n                      <jats:sub>1<\/jats:sub>\n                      ) % predicted (73%\n                      <jats:italic>versus<\/jats:italic>\n                      81%, p&lt;0.001). Patients receiving mOCS (18.9%) exhibited poorer asthma control, higher exacerbation rates and more frequent corticosteroid-related comorbidities. In multivariable models, elevated blood eosinophil count (incidence rate ratio: 1.044 per 100 cells per \u03bcL) and reduced FEV\n                      <jats:sub>1<\/jats:sub>\n                      % (odds ratio: 0.97 per 1% increase) were independent predictors of exacerbations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights the phenotypic heterogeneity of severe asthma in Greece and reveals region-specific treatment patterns and unmet clinical needs despite access to advanced therapies. These real-world findings may guide national asthma care strategies and contribute to European initiatives aimed at optimising asthma management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.01379-2025","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:55:19Z","timestamp":1771268119000},"page":"01379-2025","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world characterisation of severe asthma in Greece: results from the Greek Severe Asthma Registry"],"prefix":"10.1183","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4456-8987","authenticated-orcid":false,"given":"Evangelia","family":"Fouka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kallieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Avarlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9657-3705","authenticated-orcid":false,"given":"Konstantinos","family":"Bartziokas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Dimakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggeliki","family":"Florou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Gaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Georgatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8736-619X","authenticated-orcid":false,"given":"Paraskevi","family":"Katsaounou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Katsoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0774-3942","authenticated-orcid":false,"given":"Konstantinos","family":"Kostikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5219-6971","authenticated-orcid":false,"given":"Ourania","family":"Kotsiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Latsios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miltiadis","family":"Markatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlos","family":"Michailopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Papakosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimosthenis","family":"Papapetrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Porpodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoletta","family":"Rovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Sigala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Siopi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Solakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschalis","family":"Steiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tzanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Tzortzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Vittorakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7436-4550","authenticated-orcid":false,"given":"Eleftherios","family":"Zervas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Bakakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelios","family":"Loukides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Samitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"2026070601500890000_12.4.01379-2025.1","unstructured":"Global Initiative for Asthma (GINA) . Global Strategy for Asthma Management and Prevention. 2025. Date last accessed: 31 July 2025. https:\/\/ginasthma.org\/2025-gina-strategy-report\/"},{"key":"2026070601500890000_12.4.01379-2025.2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2147\/JAA.S468068","article-title":"Disease burden and access to biologic therapy in patients with severe asthma, 2017\u20132022: an analysis of the international severe asthma registry","volume":"17","author":"Le","year":"2024","journal-title":"J Asthma Allergy"},{"key":"2026070601500890000_12.4.01379-2025.3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaip.2021.10.059","article-title":"Effective management of severe asthma with biologic medications in adult patients: a literature review and international expert opinion","volume":"10","author":"Buhl","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026070601500890000_12.4.01379-2025.4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/CM9.0000000000001990","article-title":"Characteristics, phenotypes, mechanisms and management of severe asthma","volume":"135","author":"Chung","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"2026070601500890000_12.4.01379-2025.5","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2678"},{"key":"2026070601500890000_12.4.01379-2025.6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200906-0896OC"},{"key":"2026070601500890000_12.4.01379-2025.7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaip.2023.09.034","article-title":"Comorbidity burden in severe and nonsevere asthma: a nationwide observational study (FINASTHMA)","volume":"12","author":"Kankaanranta","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026070601500890000_12.4.01379-2025.8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaip.2024.01.023","article-title":"Phenotyping of severe asthma in the era of broad-acting anti-asthma biologics","volume":"12","author":"Bourdin","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026070601500890000_12.4.01379-2025.9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/JAA.S282205","article-title":"Revisiting late-onset asthma: clinical characteristics and association with allergy","volume":"13","author":"Quirce","year":"2020","journal-title":"J Asthma Allergy"},{"key":"2026070601500890000_12.4.01379-2025.10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17476348.2024.2449080","article-title":"Achieving sustained remission in severe asthma: goals, challenges, issues and opportunities","volume":"19","author":"Vatrella","year":"2025","journal-title":"Expert Rev Respir Med"},{"key":"2026070601500890000_12.4.01379-2025.11","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00248-2022"},{"key":"2026070601500890000_12.4.01379-2025.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2014.10.007"},{"key":"2026070601500890000_12.4.01379-2025.13","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215168"},{"key":"2026070601500890000_12.4.01379-2025.14","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jaip.2018.10.016","article-title":"The severe asthma network in Italy: findings and perspectives","volume":"7","author":"Heffler","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026070601500890000_12.4.01379-2025.15","doi-asserted-by":"crossref","first-page":"107170","DOI":"10.1016\/j.rmed.2023.107170","article-title":"Patient characteristics and eligibility for biologics in severe asthma: results from the Greek cohort of the RECOGNISE \u201creal world\u201d study","volume":"210","author":"Bakakos","year":"2023","journal-title":"Respir Med"},{"key":"2026070601500890000_12.4.01379-2025.16","doi-asserted-by":"crossref","first-page":"e70035","DOI":"10.1002\/clt2.70035","article-title":"T2-low severe asthma clinical spectrum and impact: the Greek PHOLLOW cross-sectional study","volume":"15","author":"Porpodis","year":"2025","journal-title":"Clin Transl Allergy"},{"key":"2026070601500890000_12.4.01379-2025.17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/02770903.2018.1471704","article-title":"The self-reported prevalence and disease burden of asthma in Greece","volume":"56","author":"Kourlaba","year":"2019","journal-title":"J Asthma"},{"key":"2026070601500890000_12.4.01379-2025.18","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00202013"},{"key":"2026070601500890000_12.4.01379-2025.19","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201309-307AW"},{"key":"2026070601500890000_12.4.01379-2025.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.10.053"},{"key":"2026070601500890000_12.4.01379-2025.21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01163-2019"},{"key":"2026070601500890000_12.4.01379-2025.22","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00687-2022"},{"key":"2026070601500890000_12.4.01379-2025.23","doi-asserted-by":"publisher","DOI":"10.1586\/17476348.2015.1000311"},{"key":"2026070601500890000_12.4.01379-2025.24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01497-2024"},{"key":"2026070601500890000_12.4.01379-2025.25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40266-017-0437-y","article-title":"Late-onset asthma: a diagnostic and management challenge","volume":"34","author":"Ulrik","year":"2017","journal-title":"Drugs Aging"},{"key":"2026070601500890000_12.4.01379-2025.26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.anai.2022.05.005","article-title":"Comorbidities in childhood-onset and adult-onset asthma","volume":"129","author":"Mendy","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026070601500890000_12.4.01379-2025.27","doi-asserted-by":"crossref","first-page":"106603","DOI":"10.1016\/j.rmed.2021.106603","article-title":"Adult but not childhood onset asthma is associated with the metabolic syndrome, independent from body mass index","volume":"188","author":"de Boer","year":"2021","journal-title":"Respir Med"},{"key":"2026070601500890000_12.4.01379-2025.28","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00100-2015"},{"key":"2026070601500890000_12.4.01379-2025.29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.anai.2018.07.029","article-title":"Use of biomarkers to identify phenotypes and endotypes of severe asthma","volume":"121","author":"Carr","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026070601500890000_12.4.01379-2025.30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(24)00293-5","article-title":"Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis","volume":"13","author":"Shackleford","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026070601500890000_12.4.01379-2025.31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12931-024-02812-3","article-title":"Barriers to clinical remission in severe asthma","volume":"25","author":"Farinha","year":"2024","journal-title":"Respir Res"},{"key":"2026070601500890000_12.4.01379-2025.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.10.046"},{"key":"2026070601500890000_12.4.01379-2025.33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S2213-2600(25)00037-2","article-title":"Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials","volume":"13","author":"Meulmeester","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026070601500890000_12.4.01379-2025.34","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202311-2192OC"},{"key":"2026070601500890000_12.4.01379-2025.35","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.jaip.2025.04.007","article-title":"Asthma in the biologics era: should oral corticosteroid therapy be relegated to history?","volume":"13","author":"Schleich","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026070601500890000_12.4.01379-2025.36","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.jaip.2025.04.032","article-title":"Impact of biologics initiation on oral corticosteroid use in the international severe asthma registry and the optimum patient care research database: a pooled analysis of real-world data","volume":"13","author":"Chen","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026070601500890000_12.4.01379-2025.37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.anai.2023.08.021","article-title":"Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry","volume":"132","author":"Scelo","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026070601500890000_12.4.01379-2025.38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/cea.13809","article-title":"Switching between biologics in severe asthma patients. When the first choice is not proven to be the best","volume":"51","author":"Papaioannou","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"2026070601500890000_12.4.01379-2025.39","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S328653"},{"key":"2026070601500890000_12.4.01379-2025.40","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0088-2024"},{"key":"2026070601500890000_12.4.01379-2025.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2024.08.045"},{"key":"2026070601500890000_12.4.01379-2025.42","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00413-2021"},{"key":"2026070601500890000_12.4.01379-2025.43","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4168\/aair.2021.13.3.420","article-title":"Risk factors predicting severe asthma exacerbations in adult asthmatics: a real-world clinical evidence","volume":"13","author":"Ban","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"2026070601500890000_12.4.01379-2025.44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2024-002316"},{"key":"2026070601500890000_12.4.01379-2025.45","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2024-002808"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.01379-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:50:27Z","timestamp":1783327827000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.01379-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,7,6]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1183\/23120541.01379-2025"],"URL":"https:\/\/doi.org\/10.1183\/23120541.01379-2025","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]}}}